Precision Biosciences, Inc.
Clinical trials sponsored by Precision Biosciences, Inc., explained in plain language.
-
Gene therapy aims to silence hepatitis b in first human trial
Disease control Recruiting nowThis early-stage study tests a new gene therapy called PBGENE-HBV in 45 adults with chronic hepatitis B who are already on antiviral medication. The goal is to see if the treatment is safe and can reduce the virus. Participants must have well-controlled hepatitis B and no liver s…
Phase: PHASE1 • Sponsor: Precision BioSciences, Inc. • Aim: Disease control
Last updated May 26, 2026 07:39 UTC
-
Gene-Editing breakthrough: could PBGENE-DMD fix duchenne at its source?
Disease control Recruiting nowThis early-stage trial tests a one-time gene-editing treatment called PBGENE-DMD for boys aged 2 to 7 with Duchenne muscular dystrophy (DMD). The goal is to see if it is safe and can help muscles produce dystrophin, the protein missing in DMD. The study involves 18 participants a…
Phase: PHASE1, PHASE2 • Sponsor: Precision BioSciences, Inc. • Aim: Disease control
Last updated May 22, 2026 13:52 UTC